Cargando…

Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China

BACKGROUND: Osteosarcoma is the most common primary malignant bone tumor. The current study was conducted to describe the general condition of patients with primary osteosarcoma in a single cancer center in Tianjin, China and to investigate the associated factors in osteosarcoma patients with lung m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chao, Wu, Haixiao, Xu, Guijun, Xu, Yao, Ma, Wenjuan, Li, Zhijun, Zhang, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240748/
https://www.ncbi.nlm.nih.gov/pubmed/37271825
http://dx.doi.org/10.1186/s12885-023-11024-9
_version_ 1785053839282405376
author Zhang, Chao
Wu, Haixiao
Xu, Guijun
Xu, Yao
Ma, Wenjuan
Li, Zhijun
Zhang, Jin
author_facet Zhang, Chao
Wu, Haixiao
Xu, Guijun
Xu, Yao
Ma, Wenjuan
Li, Zhijun
Zhang, Jin
author_sort Zhang, Chao
collection PubMed
description BACKGROUND: Osteosarcoma is the most common primary malignant bone tumor. The current study was conducted to describe the general condition of patients with primary osteosarcoma in a single cancer center in Tianjin, China and to investigate the associated factors in osteosarcoma patients with lung metastasis. METHODS: From February 2009 to October 2020, patients from Tianjin Medical University Cancer Institute and Hospital, China were retrospectively analyzed. The Kaplan–Meier method was used to evaluate the overall survival of osteosarcoma patients. The Cox proportional hazard regression analysis was performed to analyze the prognostic factors of all osteosarcoma patients and those patients with lung metastasis, respectively. Furthermore, risk factors for developing lung metastasis were identified in synchronous lung metastasis (SLM) and metachronous lung metastasis (MLM) patients. RESULTS: A total of 203 patients were involved and 150 patients were successfully followed up for survival status. The 5-year survival rate of osteosarcoma was 70.0% and the survival months for patients with SLM and MLM were 33.3 ± 12.6 and 45.8 ± 7.4 months, respectively. The presence of lung metastasis was one of the independent prognostic factors for prognosis of osteosarcoma. In patients with lung metastasis, twenty-one (10.3%) showed lung metastasis at the diagnosis of osteosarcoma and 67 (33%) were diagnosed with lung metastases during the later course. T3 stage (OR = 11.415, 95%CI 1.362–95.677, P = 0.025) and bone metastasis (OR = 6.437, 95%CI 1.69–24.51, P = 0.006) were risk factors of SLM occurrence. Bone metastasis (OR = 1.842, 95%CI 1.053–3.224, P = 0.032), good necrosis (≥ 90%, OR = 0.032, 95%CI 0.050–0.412, P < 0.001), elevated Ki-67 (OR = 2.958, 95%CI 1.098–7.969, P = 0.032) and elevated LDH (OR = 1.791, 95%CI 1.020–3.146, P = 0.043) were proved to be independent risk factors for developing MLM. CONCLUSION: The overall survival, prognostic factors and risk factors for lung metastasis in this single center provided insight about osteosarcoma management. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11024-9.
format Online
Article
Text
id pubmed-10240748
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102407482023-06-06 Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China Zhang, Chao Wu, Haixiao Xu, Guijun Xu, Yao Ma, Wenjuan Li, Zhijun Zhang, Jin BMC Cancer Research BACKGROUND: Osteosarcoma is the most common primary malignant bone tumor. The current study was conducted to describe the general condition of patients with primary osteosarcoma in a single cancer center in Tianjin, China and to investigate the associated factors in osteosarcoma patients with lung metastasis. METHODS: From February 2009 to October 2020, patients from Tianjin Medical University Cancer Institute and Hospital, China were retrospectively analyzed. The Kaplan–Meier method was used to evaluate the overall survival of osteosarcoma patients. The Cox proportional hazard regression analysis was performed to analyze the prognostic factors of all osteosarcoma patients and those patients with lung metastasis, respectively. Furthermore, risk factors for developing lung metastasis were identified in synchronous lung metastasis (SLM) and metachronous lung metastasis (MLM) patients. RESULTS: A total of 203 patients were involved and 150 patients were successfully followed up for survival status. The 5-year survival rate of osteosarcoma was 70.0% and the survival months for patients with SLM and MLM were 33.3 ± 12.6 and 45.8 ± 7.4 months, respectively. The presence of lung metastasis was one of the independent prognostic factors for prognosis of osteosarcoma. In patients with lung metastasis, twenty-one (10.3%) showed lung metastasis at the diagnosis of osteosarcoma and 67 (33%) were diagnosed with lung metastases during the later course. T3 stage (OR = 11.415, 95%CI 1.362–95.677, P = 0.025) and bone metastasis (OR = 6.437, 95%CI 1.69–24.51, P = 0.006) were risk factors of SLM occurrence. Bone metastasis (OR = 1.842, 95%CI 1.053–3.224, P = 0.032), good necrosis (≥ 90%, OR = 0.032, 95%CI 0.050–0.412, P < 0.001), elevated Ki-67 (OR = 2.958, 95%CI 1.098–7.969, P = 0.032) and elevated LDH (OR = 1.791, 95%CI 1.020–3.146, P = 0.043) were proved to be independent risk factors for developing MLM. CONCLUSION: The overall survival, prognostic factors and risk factors for lung metastasis in this single center provided insight about osteosarcoma management. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11024-9. BioMed Central 2023-06-05 /pmc/articles/PMC10240748/ /pubmed/37271825 http://dx.doi.org/10.1186/s12885-023-11024-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Chao
Wu, Haixiao
Xu, Guijun
Xu, Yao
Ma, Wenjuan
Li, Zhijun
Zhang, Jin
Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China
title Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China
title_full Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China
title_fullStr Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China
title_full_unstemmed Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China
title_short Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China
title_sort incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in tianjin, china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240748/
https://www.ncbi.nlm.nih.gov/pubmed/37271825
http://dx.doi.org/10.1186/s12885-023-11024-9
work_keys_str_mv AT zhangchao incidencesurvivalandassociatedfactorsestimationinosteosarcomapatientswithlungmetastasisasinglecenterexperienceof11yearsintianjinchina
AT wuhaixiao incidencesurvivalandassociatedfactorsestimationinosteosarcomapatientswithlungmetastasisasinglecenterexperienceof11yearsintianjinchina
AT xuguijun incidencesurvivalandassociatedfactorsestimationinosteosarcomapatientswithlungmetastasisasinglecenterexperienceof11yearsintianjinchina
AT xuyao incidencesurvivalandassociatedfactorsestimationinosteosarcomapatientswithlungmetastasisasinglecenterexperienceof11yearsintianjinchina
AT mawenjuan incidencesurvivalandassociatedfactorsestimationinosteosarcomapatientswithlungmetastasisasinglecenterexperienceof11yearsintianjinchina
AT lizhijun incidencesurvivalandassociatedfactorsestimationinosteosarcomapatientswithlungmetastasisasinglecenterexperienceof11yearsintianjinchina
AT zhangjin incidencesurvivalandassociatedfactorsestimationinosteosarcomapatientswithlungmetastasisasinglecenterexperienceof11yearsintianjinchina